Correction to WSJ article issued. Correct
Post# of 148172
Quote:
Correction to Investors Love the Thrill of Biotech Stocks Article on Aug. 5.
(Dow Jones) -- In July, the FDA didn't make a decision on a license application submitted by biotech firm CytoDyn, instead requesting more information from the company. "With Biotech Stocks, Investors Love the Thrill of the Chase" at 5:30 a.m. ET on Aug. 5, incorrectly said the FDA refused to grant the license.
Dow Jones Newswires